Meconium aspiration syndrome: Difference between revisions

No edit summary
No edit summary
Line 3: Line 3:
*Presentation ranges from mild respiratory distress to life-threatening respiratory failure  
*Presentation ranges from mild respiratory distress to life-threatening respiratory failure  
*Incidence is 2-10% of infants born through MSAF
*Incidence is 2-10% of infants born through MSAF
*Thought to be associated with fetal hypoxia and post-term delivery
*Causes hypoxemia and acidosis via airway obstruction, chemical irritation/inflammation, infection, and surfactant inactivation
*Causes hypoxemia and acidosis via airway obstruction, chemical irritation/inflammation, infection, and surfactant inactivation
*Associated with persistent pulmonary hypertension of the newborn (PPHN)
*Associated with persistent pulmonary hypertension of the newborn (PPHN)
Line 24: Line 25:
*Pulmonary edema
*Pulmonary edema
*Blood aspiration
*Blood aspiration
*Pulmonary hypertension
*Congenital heart disease
*Respiratory distress syndrome


==Evaluation==
==Evaluation==
Line 48: Line 52:
==Management==
==Management==
*Empiric antibiotics while awaiting culture results (because of difficulty differentiating between pneumonia initially)
*Empiric antibiotics while awaiting culture results (because of difficulty differentiating between pneumonia initially)
*Prevention
**Fetal heart rate monitoring intrapartum to  reduce risk of fetal hypoxia
**Induction of labor after 41 weeks gestation to reduce postmature delivery
**Amnioinfusion with isotonic fluid to dilute thick meconium is NOT routinely recommended


==Disposition==
==Disposition==

Revision as of 18:42, 11 October 2017

Background

  • May cause meconium aspiration syndrome (MAS) in a newborn infant that was born through meconium-stained amniotic fluid (MSAF)
  • Presentation ranges from mild respiratory distress to life-threatening respiratory failure
  • Incidence is 2-10% of infants born through MSAF
  • Thought to be associated with fetal hypoxia and post-term delivery
  • Causes hypoxemia and acidosis via airway obstruction, chemical irritation/inflammation, infection, and surfactant inactivation
  • Associated with persistent pulmonary hypertension of the newborn (PPHN)

Clinical Features

  • Tachypnea
  • Cyanosis
  • Accessory muscle use (intercostal/subxiphoid retractions, paradoxical breathing, grunting, nasal flaring)
  • Barrel-shaped chest
  • Rales and rhonchi on lung auscultation
  • Pneumothorax
  • Pneumomediastinum
  • Usually develop symptoms immediately after birth, but sometimes are born asymptomatic and develop symptoms as meconium moves into lower tracheobronchial tree

Differential Diagnosis

  • Transient tachypnea of the newborn (TTN)
  • Sepsis
  • Pneumonia
  • Delayed transition from fetal circulation
  • Pneumothorax
  • Pulmonary edema
  • Blood aspiration
  • Pulmonary hypertension
  • Congenital heart disease
  • Respiratory distress syndrome

Evaluation

  • Workup
    • CXR
    • ABG
    • Echocardiogram
    • Blood and sputum cultures
  • Clinical diagnosis based on the following:
    • Evidence of meconium on infant
    • Respiratory distress shortly after birth
    • Characteristic CXR findings
      • Initially, streaky, linear densities
      • Next, development of hyperinflated lungs and flattened diaphragm
      • Finally, diffuse patchy opacities (may appear similar to ARDS if severe)
    • If intubation required, meconium visualized in trachea
  • Ways to differentiate between other causes of respiratory distress in a neonate:
    • TTN is more common in late preterm infants (34-37 weeks) and RDS in preterm infants, whereas MAS more common in postmature infants (>41 weeks)
    • Delayed transition from fetal circulation symptoms improve more quickly than those of MAS
    • Congenital cyanotic heart disease is differentiated by physical exam (murmurs, hepatomegaly), CXR (cardiac size/shape), and echocardiogram (cardiac anatomy and function)

Management

  • Empiric antibiotics while awaiting culture results (because of difficulty differentiating between pneumonia initially)
  • Prevention
    • Fetal heart rate monitoring intrapartum to reduce risk of fetal hypoxia
    • Induction of labor after 41 weeks gestation to reduce postmature delivery
    • Amnioinfusion with isotonic fluid to dilute thick meconium is NOT routinely recommended


Disposition

See Also

External Links

References